跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 294 条关于
“PKD1”
全部
294
临床试验
231
药物
47
机构
1
资讯
15
去年
Regulus Therapeutics' Farabursen Shows Promise in ADPKD Phase 1b Trial and Gains FDA Agreement on Phase 3 Design
去年
Novartis Acquires Regulus Therapeutics for $800M, Expanding Kidney Disease Portfolio
10个月前
Helex Secures $3.5M Seed Funding to Develop Non-Viral Gene Therapy for Polycystic Kidney Disease
2年前
Replimune's RP1 Shows Durable Responses in Anti-PD1 Failed Melanoma
去年
PYC Therapeutics' PKD Drug, PYC-003, Enters Human Clinical Trials
去年
Anti-PD1 Precision Therapy Shows Promise in Unresectable Stage III NSCLC Trial
去年
Replimune's RP1 Plus Nivolumab Shows Promise in Anti-PD1 Failed Melanoma
去年
Replimune's RP1 Plus Nivolumab Shows Promise in Anti-PD1 Failed Melanoma
去年
Replimune's RP1 Plus Nivolumab Shows Promising Results in Anti-PD1 Failed Melanoma
去年
HAIC Plus Lenvatinib and PD-1 Inhibitors Improve Outcomes in Advanced Intrahepatic Cholangiocarcinoma
第 1 页,共 2 页
上一页
下一页